> Details

Bartsch, Detlef K.; Albers, Max B.; Lopez, Caroline L.; Apitzsch, Jonas C.; Walthers, Eduard M.; Fink, Ludger; Fendrich, Volker; Slater, Emily P.; Waldmann, Jens; Anlauf, Martin

Bronchopulmonary Neuroendocrine Neoplasms and Their Precursor Lesions in Multiple Endocrine Neoplasia Type 1

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Bronchopulmonary Neuroendocrine Neoplasms and Their Precursor Lesions in Multiple Endocrine Neoplasia Type 1
  • Contributor: Bartsch, Detlef K.; Albers, Max B.; Lopez, Caroline L.; Apitzsch, Jonas C.; Walthers, Eduard M.; Fink, Ludger; Fendrich, Volker; Slater, Emily P.; Waldmann, Jens; Anlauf, Martin
  • Published: S. Karger AG, 2016
  • Published in: Neuroendocrinology, 103 (2016) 3-4, Seite 240-247
  • Language: English
  • DOI: 10.1159/000435921
  • ISSN: 0028-3835; 1423-0194
  • Origination:
  • Footnote:
  • Description: <b><i>Objective:</i></b> The prevalence and clinical behavior of bronchopulmonary neuroendocrine tumors (bNET) associated with multiple endocrine neoplasia type 1 (MEN1) are not well defined. This study aimed to determine the prevalence, potential precursor lesions and prognosis of bNET in patients with MEN1. <b><i>Methods:</i></b> A database of 75 prospectively collected MEN1 cases was retrospectively analyzed for bNET. Patient characteristics, imaging and treatment were evaluated. Resection specimens of operated patients were reassessed by two specialized pathologists. Available CT scans of the whole cohort were reviewed to determine the prevalence of bronchopulmonary nodules. <b><i>Results:</i></b> Five of the 75 MEN1 patients (6.6%; 2 male, 3 female) developed histologically confirmed bNET after a median follow-up of 134 months. The median age at diagnosis of bNET was 47 years (range 31-67), and all patients were asymptomatic. Four patients underwent anatomic lung resections with lymphadenectomy; the remaining patient with multiple lesions had only a wedge resection of the largest bNET. Tumor sizes ranged from 7 to 32 mm in diameter, and all bNET were well differentiated. Two patients had lymph node metastases. Two of 4 reevaluated resection specimens revealed multifocal bNET, and 3 specimens showed tumorlets (up to 3) associated with multifocal areas of a neuroendocrine cell hyperplasia within the subsegmental bronchi. One bNET-related death (1.3%) occurred during long-term follow-up. Review of the available CT scans of the patients without proven bNET revealed small bronchopulmonary lesions (≥3 mm) in 16 of 53 cases (30.2%). <b><i>Conclusions:</i></b> bNET in MEN1 might be more common than previously recognized. Their natural course seems to be rather benign. Multifocal tumorlets and multifocal neuroendocrine cell hyperplasia might represent their precursor lesions.